Modified release composition of highly soluble drugs

Details Modified release composition of highly soluble drugs Modified release composition of highly soluble drugs

2011-07-12

2011-07-12

Desai, Anand U (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

C424S400000, C424S464000, C424S465000, C424S468000

Reexamination Certificate

active

07976871

ABSTRACT:
A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents. Present invention can optionally comprise additionally another active ingredient as an immediate release form or modified release form. Present invention also relates to a process for preparing the said formulation.

REFERENCES:
patent: 2566582 (1951-07-01), Rotner
patent: 2968158 (1961-01-01), Ruschig et al.
patent: 3097242 (1963-07-01), Hoehn et al.
patent: 3174901 (1965-03-01), Sterne
patent: 3454635 (1969-07-01), Weber et al.
patent: 3654357 (1972-04-01), Bretschneider et al.
patent: 3668215 (1972-06-01), Plumpe et al.
patent: 3669966 (1972-06-01), Ambrogi
patent: 3708486 (1973-01-01), Kutter et al.
patent: 3801495 (1974-04-01), Gould
patent: 3957833 (1976-05-01), Chodnekar et al.
patent: 4080472 (1978-03-01), Bohuon
patent: 4363802 (1982-12-01), Matsumura et al.
patent: 4376777 (1983-03-01), Kawanatsu et al.
patent: 4572912 (1986-02-01), Yoshioka et al.
patent: 4725610 (1988-02-01), Meguro et al.
patent: 4775687 (1988-10-01), Meguro et al.
patent: 4791125 (1988-12-01), Clark
patent: 4835184 (1989-05-01), Hugelin et al.
patent: 5002953 (1991-03-01), Hindley
patent: 5061717 (1991-10-01), Clark et al.
patent: 5098725 (1992-03-01), Rotman et al.
patent: 5104888 (1992-04-01), Yoshioka et al.
patent: 5183823 (1993-02-01), Sohda et al.
patent: 5225426 (1993-07-01), Miyaoka et al.
patent: 5232945 (1993-08-01), Hulin
patent: 5264451 (1993-11-01), Kees
patent: 5306726 (1994-04-01), Hulin
patent: 5334604 (1994-08-01), Goldstein et al.
patent: 5399357 (1995-03-01), Akiyama et al.
patent: 5472704 (1995-12-01), Santus et al.
patent: 5478852 (1995-12-01), Olefsky et al.
patent: 5589492 (1996-12-01), Haigh
patent: 5945125 (1999-08-01), Kim
patent: 6031004 (2000-02-01), Timmins et al.
patent: 6048883 (2000-04-01), Haigh et al.
patent: 6296874 (2001-10-01), Cutie
patent: 6337091 (2002-01-01), Kim et al.
patent: 6340475 (2002-01-01), Shell et al.
patent: 6660300 (2003-12-01), Timmins et al.
patent: 6790459 (2004-09-01), Cheng et al.
patent: 6866866 (2005-03-01), Chen et al.
patent: 2004/0022849 (2004-02-01), Castan et al.
patent: 0008203 (1980-02-01), None
patent: 0155845 (1985-09-01), None
patent: 0332332 (1989-09-01), None
patent: 0428312 (1991-05-01), None
patent: 0533933 (1993-03-01), None
patent: 0842925 (1998-05-01), None
patent: WO 92/18501 (1992-10-01), None
patent: WO 93/02079 (1993-02-01), None
patent: WO 93/22445 (1993-11-01), None
patent: WO 94/05659 (1994-03-01), None
Merck Index Online: accessed Aug. 4, 2008 for Niacin, Sodium Valproate.
Merck Index Online, accessed Aug. 4, 2008 for Niacin and Sodium Valproate.

Affiliated with

Also associated with

Rating

Modified release composition of highly soluble drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified release composition of highly soluble drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified release composition of highly soluble drugs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2738985